BW Fundamental Analysis - BABCOCK & WILCOX ENTERPR

Fundamental Rating

Overall BW gets a fundamental rating of 2 out of 10. We evaluated BW against 92 industry peers in the Electrical Equipment industry. Both the profitability and financial health of BW have multiple concerns. BW does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BW has reported negative net income.

In the past year BW has reported a negative cash flow from operations.

In the past 5 years BW reported 4 times negative net income.

In the past 5 years BW always reported negative operating cash flow.

1.2 Ratios

BW has a Return On Assets (-23.28%) which is in line with its industry peers.

The Return On Invested Capital of BW (16.43%) is better than 95.65% of its industry peers.

The Average Return On Invested Capital over the past 3 years for BW is significantly below the industry average of 10.15%.

The 3 year average ROIC (3.67%) for BW is below the current ROIC(16.43%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	-23.28%
ROE	N/A
ROIC	16.43%

ROA(3y)-13.87%

ROA(5y)-8.19%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)3.67%

ROIC(5y)3.7%

1.3 Margins

Looking at the Operating Margin, with a value of 6.02%, BW is in the better half of the industry, outperforming 73.91% of the companies in the same industry.

In the last couple of years the Operating Margin of BW has grown nicely.

BW has a Gross Margin (26.17%) which is in line with its industry peers.

BW's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	6.02%
PM (TTM)	N/A
GM	26.17%

OM growth 3Y9.27%

OM growth 5Y41.42%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.18%

GM growth 5Y5.75%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BW is creating value.

BW has more shares outstanding than it did 1 year ago.

The number of shares outstanding for BW has been increased compared to 5 years ago.

Compared to 1 year ago, BW has a worse debt to assets ratio.

2.2 Solvency

BW has an Altman-Z score of -2.23. This is a bad value and indicates that BW is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -2.23, BW is not doing good in the industry: 70.65% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-2.23

ROIC/WACC2.22

WACC7.4%

2.3 Liquidity

BW has a Current Ratio of 1.00. This is a bad value and indicates that BW is not financially healthy enough and could expect problems in meeting its short term obligations.

BW has a worse Current ratio (1.00) than 70.65% of its industry peers.

A Quick Ratio of 0.87 indicates that BW may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.87, BW is in line with its industry, outperforming 42.39% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1
Quick Ratio	0.87

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.08%.

The Revenue for BW has decreased by -33.75% in the past year. This is quite bad

The Revenue has been decreasing by -3.54% on average over the past years.

EPS 1Y (TTM)-12.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-215%

Revenue 1Y (TTM)-33.75%

Revenue growth 3Y-0.28%

Revenue growth 5Y-3.54%

Sales Q2Q%-38.31%

3.2 Future

BW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.79% yearly.

The Revenue is expected to decrease by -3.90% on average over the next years.

EPS Next Y12.34%

EPS Next 2Y37.32%

EPS Next 3Y26.79%

EPS Next 5YN/A

Revenue Next Year-25.22%

Revenue Next 2Y-10.12%

Revenue Next 3Y-3.9%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BW. In the last year negative earnings were reported.

Also next year BW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BW is valued cheaply inside the industry as 81.52% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	17.04

4.3 Compensation for Growth

BW's earnings are expected to grow with 26.79% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y37.32%

EPS Next 3Y26.79%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BW does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BABCOCK & WILCOX ENTERPR

NYSE:BW (10/21/2025, 8:04:01 PM)

After market: 3.35 -0.04 (-1.18%)

3.39

-0.22 (-6.09%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)08-11 2025-08-11/amc

Earnings (Next)11-05 2025-11-05/amc

Inst Owners60.96%

Inst Owner Change-0.44%

Ins Owners3.8%

Ins Owner Change12.98%

Market Cap342.73M

Analysts80

Price Target2.72 (-19.76%)

Short Float %2.97%

Short Ratio1.12

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.2

Dividend Growth(5Y)N/A

DP-9.07%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-279.85%

Min EPS beat(2)-579.61%

Max EPS beat(2)19.9%

EPS beat(4)2

Avg EPS beat(4)-1222.51%

Min EPS beat(4)-4779.86%

Max EPS beat(4)449.52%

EPS beat(8)2

Avg EPS beat(8)-1380.43%

EPS beat(12)2

Avg EPS beat(12)-966.37%

EPS beat(16)4

Avg EPS beat(16)-697.83%

Revenue beat(2)1

Avg Revenue beat(2)-5.71%

Min Revenue beat(2)-19.61%

Max Revenue beat(2)8.19%

Revenue beat(4)1

Avg Revenue beat(4)-7.8%

Min Revenue beat(4)-19.61%

Max Revenue beat(4)8.19%

Revenue beat(8)1

Avg Revenue beat(8)-9.02%

Revenue beat(12)5

Avg Revenue beat(12)-2.17%

Revenue beat(16)6

Avg Revenue beat(16)-2.84%

PT rev (1m)0%

PT rev (3m)6.67%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-136.35%

EPS NY rev (1m)0%

EPS NY rev (3m)-234.54%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-16.59%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-12.31%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.57
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	17.04

EPS(TTM)-1.4

EYN/A

EPS(NY)-0.12

Fwd EYN/A

FCF(TTM)-1.35

FCFYN/A

OCF(TTM)-1.25

OCFYN/A

SpS5.95

BVpS-3.06

TBVpS-3.76

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-23.28%
ROE	N/A
ROCE	20.79%
ROIC	16.43%
ROICexc	18.77%
ROICexgc	35.25%
OM	6.02%
PM (TTM)	N/A
GM	26.17%
FCFM	N/A

ROA(3y)-13.87%

ROA(5y)-8.19%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)3.67%

ROIC(5y)3.7%

ROICexc(3y)4.08%

ROICexc(5y)4.44%

ROICexgc(3y)6%

ROICexgc(5y)6.49%

ROCE(3y)4.64%

ROCE(5y)4.69%

ROICexcg growth 3Y18.44%

ROICexcg growth 5Y33.31%

ROICexc growth 3Y21.33%

ROICexc growth 5Y31.59%

OM growth 3Y9.27%

OM growth 5Y41.42%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.18%

GM growth 5Y5.75%

F-Score3

Asset Turnover0.85

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	5.46
Cap/Depr	85.93%
Cap/Sales	1.71%
Interest Coverage	0.91
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1
Quick Ratio	0.87
Altman-Z	-2.23

F-Score3

WACC7.4%

ROIC/WACC2.22

Cap/Depr(3y)56.25%

Cap/Depr(5y)50.83%

Cap/Sales(3y)1.46%

Cap/Sales(5y)1.35%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-12.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-215%

EPS Next Y12.34%

EPS Next 2Y37.32%

EPS Next 3Y26.79%

EPS Next 5YN/A

Revenue 1Y (TTM)-33.75%

Revenue growth 3Y-0.28%

Revenue growth 5Y-3.54%

Sales Q2Q%-38.31%

Revenue Next Year-25.22%

Revenue Next 2Y-10.12%

Revenue Next 3Y-3.9%

Revenue Next 5YN/A

EBIT growth 1Y68.04%

EBIT growth 3Y8.96%

EBIT growth 5Y36.41%

EBIT Next Year-5.64%

EBIT Next 3Y13.99%

EBIT Next 5YN/A

FCF growth 1Y-2423.11%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1276.98%

OCF growth 3YN/A

OCF growth 5YN/A

BABCOCK & WILCOX ENTERPR (BW) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens